Cover Image


View/Hide Left Panel

Finkelstein, R.A., K.Fujita, and J.J.La Spalluto. 1971. Procholeragenoid: An aggregated intermediate in the formation of choleragenoid. J.Immunol. 107:1043–1051.

Finkelstein, R.A., C.V.Sciortino, L.C.Rieker M.F.Burks, and M. M.Boesman-Finkelstein. 1984. Preparation of procoligenoids from Escherichia coli heat-labile enterotoxins. Infect. Immun. 45(2): 518–521.

Fujita, K., and R.A.Finkelstein. 1972. Antitoxic immunity in experimental cholera: Comparison of immunity induced perorally and parenterally in mice. J. Infect. Dis. 125:647–655.

Honda, T., and R.A.Finkelstein. 1979. Selection and characterization of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin. Proc. Natl. Acad. Sci. USA 76:2052–2056.

Jacob, C.D., M.Sela, and R.Arnon. 1983. Antibodies against synthetic peptides of the B subunit of cholera toxin: Cross-reaction and neutralization of the toxin. Proc. Natl. Acad. Sci. USA 80:7611–7615.

Kaper, J.B. 1986. Personal communication, University of Maryland School of Medicine, Baltimore.

Kaper, J.B., H.Lockman, M.M.Baldini, and M.M.Levine. 1984a. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature 308(5960):655–658.

Kaper, J.B., H.Lockman, M.M.Baldini, and M.M.Levine. 1984b. A recombinant live oral cholera vaccine. Biotechnology (April): 345–349.

Kaper, J.B., M.M.Levine, H.A.Lockman, M.M.Baldini, R.E.Black, M.L.Clements, and J.G.Morris. 1985. Development and testing of a recombinant live oral cholera vaccine. Pp. 107–111 in Vaccines 85, R.A.Lerner, R.M.Chanock, and F.Brown, eds. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory.

Kaper, J.B., M.M.Levine, D.A.Herrington, J.Michalski, J.Galen, R. Hall, and J.Ketley. 1986. Recent advances in developing a safe and effective live oral attenuated Vibrio cholerae vaccine. Abstracts of the U.S.-Japan Cooperative Medical Science Program, 22nd Joint Conference on Cholera, Toyama, Japan.

Khan, M.U., and W.B.Greenough, III. 1985. Pp. 37–52 in Bacterial Diarrheal Diseases, T.Takeda and T.Miwatani, eds. Tokyo: Scientific Publishers.

Klipstein, F.A., R.F.Engert, and R.A.Houghten. 1983. Protection in rabbits immunized with a vaccine of Escherichia coli heat-stabile toxin cross-linked to the heat-labile toxin B subunit. Infect. Immun. 40:888–893.

Levine, M.M., J.B.Kaper, R.E.Black, and M.L.Clements. 1983. New knowledge on the pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:510–550.

Levine, M.M., R.E.Black, M.L.Clements, C.Lanata, S.Sears, T.Honda, C.R.Young, and R.A.Finkelstein. 1984. Evaluation in humans of attenuated Vibrio cholerae El Jor Ogawa strain Texas Star-SR as a live oral vaccine. Infect. Immun. 43(2):515–522.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement